Review




Structured Review

Proteintech tnfr1
Autophagy limits CAR‐T cell‐mediated cytotoxicity by suppressing TNF‐α induced apoptosis. (A) Volcano plot showing varied genes in Nalm6 cells with the addition of vehicle (as control) and autophinib (log 2 FC > 1 and P < 0.05). (B) Volcano plot showing varied genes between sgControl and indicated RB1CC1 KO Nalm6 cells (log 2 FC > 1 and P < 0.05). (C) KEGG pathway enrichment analysis of varied genes identified in RNA sequencing for Nalm6 cells treated with vehicle (as control) and autophinib. (D) Western blotting showing the expression levels of Caspase‐8, Cleaved caspase‐8, Caspase‐9, Cleaved caspase‐9 and p62 proteins after the addition of vehicle (as control), autophinib and SAR405 in Nalm6 and Raji cells when co‐cultured with or without CD19 CAR‐T cells. GAPDH was used as a loading control. (E) Western blotting showing the expression levels of Caspase‐8, Cleaved caspase‐8, Caspase‐9, Cleaved caspase‐9 and p62 proteins in sgControl and indicated gene‐KO (sgBECN1, sgRB1CC1) Nalm6 and Raji cells when co‐cultured with or without CD19 CAR‐T cells. GAPDH was used as a loading control. (F) Expression of TNFRSF1A mRNA by RT‐qPCR and <t>TNFR1</t> protein by western blotting in Nalm6 and Raji cells after addition of vehicle (as control), autophinib and SAR405 ( n = 3). Values are shown as the mean ± SD. Statistical differences among three groups in each cell line are calculated with one‐way ANOVA with tests. (G‐H) Cytotoxic analysis of sgControl and indicated gene‐KO (sgTNFRSF1A) Nalm6 and Raji cells co‐cultured with CD19 CAR‐T cells (E:T ratio = 1:4) when treated with vehicle (as control), autophinib and SAR405 and then with or without TNF‐block ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA with tests. (I) Cytotoxic analysis of sgControl and indicated gene‐KO (sgBECN1, sgRB1CC1, sgTNFRSF1A) Nalm6 and Raji cells co‐cultured with CD19 CAR‐T cells (E: T ratio = 1: 4) when treated with or without TNF block ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA with tests. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0,001; ns: not significant. Abbreviations: ANOVA analysis of variance; CAR‐T chimeric antigen receptor T; E:T effector:target; FC fold change; FC fold change; KO knockout; KEGG Kyoto Encyclopedia of Genes and Genomes; RT‐qPCR real‐time quantitative polymerase chain reaction; ns: not significant; SD standard deviation; sg single guide; TNF tumor necrosis factor; TNFR1 tumor necrosis factor receptor 1.
Tnfr1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+cell-type+deconvolution/TNFR1+Antibody/pmc10958674-153-42-43
Average 95 stars, based on 124 article reviews
tnfr1 - by Bioz Stars, 2026-11
95/100 stars

Images

1) Product Images from "Targeting autophagy overcomes cancer‐intrinsic resistance to CAR‐T immunotherapy in B‐cell malignancies"

Article Title: Targeting autophagy overcomes cancer‐intrinsic resistance to CAR‐T immunotherapy in B‐cell malignancies

Journal: Cancer Communications

doi: 10.1002/cac2.12525

Autophagy limits CAR‐T cell‐mediated cytotoxicity by suppressing TNF‐α induced apoptosis. (A) Volcano plot showing varied genes in Nalm6 cells with the addition of vehicle (as control) and autophinib (log 2 FC > 1 and P < 0.05). (B) Volcano plot showing varied genes between sgControl and indicated RB1CC1 KO Nalm6 cells (log 2 FC > 1 and P < 0.05). (C) KEGG pathway enrichment analysis of varied genes identified in RNA sequencing for Nalm6 cells treated with vehicle (as control) and autophinib. (D) Western blotting showing the expression levels of Caspase‐8, Cleaved caspase‐8, Caspase‐9, Cleaved caspase‐9 and p62 proteins after the addition of vehicle (as control), autophinib and SAR405 in Nalm6 and Raji cells when co‐cultured with or without CD19 CAR‐T cells. GAPDH was used as a loading control. (E) Western blotting showing the expression levels of Caspase‐8, Cleaved caspase‐8, Caspase‐9, Cleaved caspase‐9 and p62 proteins in sgControl and indicated gene‐KO (sgBECN1, sgRB1CC1) Nalm6 and Raji cells when co‐cultured with or without CD19 CAR‐T cells. GAPDH was used as a loading control. (F) Expression of TNFRSF1A mRNA by RT‐qPCR and TNFR1 protein by western blotting in Nalm6 and Raji cells after addition of vehicle (as control), autophinib and SAR405 ( n = 3). Values are shown as the mean ± SD. Statistical differences among three groups in each cell line are calculated with one‐way ANOVA with tests. (G‐H) Cytotoxic analysis of sgControl and indicated gene‐KO (sgTNFRSF1A) Nalm6 and Raji cells co‐cultured with CD19 CAR‐T cells (E:T ratio = 1:4) when treated with vehicle (as control), autophinib and SAR405 and then with or without TNF‐block ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA with tests. (I) Cytotoxic analysis of sgControl and indicated gene‐KO (sgBECN1, sgRB1CC1, sgTNFRSF1A) Nalm6 and Raji cells co‐cultured with CD19 CAR‐T cells (E: T ratio = 1: 4) when treated with or without TNF block ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA with tests. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0,001; ns: not significant. Abbreviations: ANOVA analysis of variance; CAR‐T chimeric antigen receptor T; E:T effector:target; FC fold change; FC fold change; KO knockout; KEGG Kyoto Encyclopedia of Genes and Genomes; RT‐qPCR real‐time quantitative polymerase chain reaction; ns: not significant; SD standard deviation; sg single guide; TNF tumor necrosis factor; TNFR1 tumor necrosis factor receptor 1.
Figure Legend Snippet: Autophagy limits CAR‐T cell‐mediated cytotoxicity by suppressing TNF‐α induced apoptosis. (A) Volcano plot showing varied genes in Nalm6 cells with the addition of vehicle (as control) and autophinib (log 2 FC > 1 and P < 0.05). (B) Volcano plot showing varied genes between sgControl and indicated RB1CC1 KO Nalm6 cells (log 2 FC > 1 and P < 0.05). (C) KEGG pathway enrichment analysis of varied genes identified in RNA sequencing for Nalm6 cells treated with vehicle (as control) and autophinib. (D) Western blotting showing the expression levels of Caspase‐8, Cleaved caspase‐8, Caspase‐9, Cleaved caspase‐9 and p62 proteins after the addition of vehicle (as control), autophinib and SAR405 in Nalm6 and Raji cells when co‐cultured with or without CD19 CAR‐T cells. GAPDH was used as a loading control. (E) Western blotting showing the expression levels of Caspase‐8, Cleaved caspase‐8, Caspase‐9, Cleaved caspase‐9 and p62 proteins in sgControl and indicated gene‐KO (sgBECN1, sgRB1CC1) Nalm6 and Raji cells when co‐cultured with or without CD19 CAR‐T cells. GAPDH was used as a loading control. (F) Expression of TNFRSF1A mRNA by RT‐qPCR and TNFR1 protein by western blotting in Nalm6 and Raji cells after addition of vehicle (as control), autophinib and SAR405 ( n = 3). Values are shown as the mean ± SD. Statistical differences among three groups in each cell line are calculated with one‐way ANOVA with tests. (G‐H) Cytotoxic analysis of sgControl and indicated gene‐KO (sgTNFRSF1A) Nalm6 and Raji cells co‐cultured with CD19 CAR‐T cells (E:T ratio = 1:4) when treated with vehicle (as control), autophinib and SAR405 and then with or without TNF‐block ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA with tests. (I) Cytotoxic analysis of sgControl and indicated gene‐KO (sgBECN1, sgRB1CC1, sgTNFRSF1A) Nalm6 and Raji cells co‐cultured with CD19 CAR‐T cells (E: T ratio = 1: 4) when treated with or without TNF block ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA with tests. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0,001; ns: not significant. Abbreviations: ANOVA analysis of variance; CAR‐T chimeric antigen receptor T; E:T effector:target; FC fold change; FC fold change; KO knockout; KEGG Kyoto Encyclopedia of Genes and Genomes; RT‐qPCR real‐time quantitative polymerase chain reaction; ns: not significant; SD standard deviation; sg single guide; TNF tumor necrosis factor; TNFR1 tumor necrosis factor receptor 1.

Techniques Used: Control, RNA Sequencing, Western Blot, Expressing, Cell Culture, Quantitative RT-PCR, Blocking Assay, Knock-Out, Real-time Polymerase Chain Reaction, Standard Deviation

STAT1/IRF1 axis mediates the upregulation of CXCL10 and CXCL11 induced by autophagy targeting. (A‐B) Western blotting showing the expression levels of STAT1, pSTAT1, and IRF1 proteins in Nalm6 and Raji cells after the addition of autophagy inhibitors or the knockout of RB1CC1 ( n = 3). GAPDH was used as a loading control. The histograms showing the expression of STAT1 and IRF1 mRNA by RT‐qPCR quantification. Values are shown as the mean ± SD. Statistical differences are calculated with one‐way ANOVA tests. (C‐D) Western blotting showing the expression levels of STAT1 and IRF1 proteins in Nalm6 and Raji cells after the addition of autophagy inhibitors and the silencing of STAT1 ( n = 3). GAPDH was used as a loading control. The histograms showing the expression of STAT1 and IRF1 mRNA by RT‐qPCR quantification. Values are shown as the mean ± SD. Statistical differences are calculated with one‐way ANOVA tests. (E‐F) Expression of CXCL10 and CXCL11 mRNA by RT‐qPCR and ELISA quantification of CXCL10 and CXCL11 protein levels in the supernatants of shControl, shSTAT1 and shIRF1 Nalm6 and Raji cells ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA tests. (G‐H) ChIP‐qPCR showing the binding of STAT1 and IRF1 to the promoter region of CXCL10 and CXCL11 ( n = 3). Values are shown as the mean ± SD. Statistical differences for each cell line are calculated with unpaired Student's t tests. (I) Graphic abstract: in the proposed model, inhibition of cancer cell‐autonomous autophagy leads to accumulation of cytosolic DNA, which thereby not only suppresses cancer cell survival by inducing TNFR1‐TNF‐α mediated apoptosis but also promotes the CAR‐T cell recruitment in tumor microenvironment via STAT1/IRF1‐dependent activation of chemokine signaling. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0,001; ns: not significant. Abbreviations: ANOVA analysis of variance; CAR‐T, chimeric antigen receptor T; ChIP, chromatin immunoprecipitation; CXCL CXC, chemokine ligand; ELISA, enzyme‐linked immunosorbent assay; FC, fold change; IRF, interferon regulatory factor; ns: not significant; RT‐qPCR, real‐time quantitative polymerase chain reaction; SD, standard deviation; sh short hairpin; STAT, signal transducers and activators of transcription.
Figure Legend Snippet: STAT1/IRF1 axis mediates the upregulation of CXCL10 and CXCL11 induced by autophagy targeting. (A‐B) Western blotting showing the expression levels of STAT1, pSTAT1, and IRF1 proteins in Nalm6 and Raji cells after the addition of autophagy inhibitors or the knockout of RB1CC1 ( n = 3). GAPDH was used as a loading control. The histograms showing the expression of STAT1 and IRF1 mRNA by RT‐qPCR quantification. Values are shown as the mean ± SD. Statistical differences are calculated with one‐way ANOVA tests. (C‐D) Western blotting showing the expression levels of STAT1 and IRF1 proteins in Nalm6 and Raji cells after the addition of autophagy inhibitors and the silencing of STAT1 ( n = 3). GAPDH was used as a loading control. The histograms showing the expression of STAT1 and IRF1 mRNA by RT‐qPCR quantification. Values are shown as the mean ± SD. Statistical differences are calculated with one‐way ANOVA tests. (E‐F) Expression of CXCL10 and CXCL11 mRNA by RT‐qPCR and ELISA quantification of CXCL10 and CXCL11 protein levels in the supernatants of shControl, shSTAT1 and shIRF1 Nalm6 and Raji cells ( n = 3). Values are shown as the mean ± SD. Statistical differences are calculated with two‐way ANOVA tests. (G‐H) ChIP‐qPCR showing the binding of STAT1 and IRF1 to the promoter region of CXCL10 and CXCL11 ( n = 3). Values are shown as the mean ± SD. Statistical differences for each cell line are calculated with unpaired Student's t tests. (I) Graphic abstract: in the proposed model, inhibition of cancer cell‐autonomous autophagy leads to accumulation of cytosolic DNA, which thereby not only suppresses cancer cell survival by inducing TNFR1‐TNF‐α mediated apoptosis but also promotes the CAR‐T cell recruitment in tumor microenvironment via STAT1/IRF1‐dependent activation of chemokine signaling. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0,001; ns: not significant. Abbreviations: ANOVA analysis of variance; CAR‐T, chimeric antigen receptor T; ChIP, chromatin immunoprecipitation; CXCL CXC, chemokine ligand; ELISA, enzyme‐linked immunosorbent assay; FC, fold change; IRF, interferon regulatory factor; ns: not significant; RT‐qPCR, real‐time quantitative polymerase chain reaction; SD, standard deviation; sh short hairpin; STAT, signal transducers and activators of transcription.

Techniques Used: Western Blot, Expressing, Knock-Out, Control, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, ChIP-qPCR, Binding Assay, Inhibition, Activation Assay, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction, Standard Deviation

Related Articles

CCK-8 Assay:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Multiple Displacement Amplification:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Real-time Polymerase Chain Reaction:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

SYBR Green Assay:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Live Cell Imaging:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Electrophoresis:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Spectrophotometry:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Polymerase Chain Reaction:

Article Title: Rhoifolin inhibits ferroptosis and alleviates pulmonary arterial hypertension via the TNF-α/TNF-R1/CASP8/CASP3 pathway.
Article Snippet: Background: Pulmonary arterial hypertension (PAH) is a fatal disease driven by progressive vascular remodeling.. Emerging evidence links ferroptosis, an iron-dependent form of regulated cell death, to PAH pathogenesis, suggesting that inhibiting ferroptosis is a promising therapeutic strategy.. Rhoifolin (ROF), a natural flavonoid with multiple bioactivities, has not been studied in PAH.

Cell-Signaling:

Article Title: ADAR1 Inhibits ZBP1 ‐Driven Neuronal Necroptosis After Intracerebral Hemorrhage
Article Snippet: Necroptosis is a critical response to secondary brain injury following intracerebral hemorrhage (ICH).. ZDNA Binding Protein 1 (ZBP1) binds to dsRNA and promotes the activation of ReceptorInteracting Protein Kinase 3 (RIPK3).. This study investigated whether Adenosine Deaminase Acting on RNA 1 (ADAR1) inhibits neuronal necroptosis after ICH.

Membrane:

Article Title: Integrated Multi-Omics Analyses Identify Core Determinants Governing Newcastle Disease Virus Oncolytic Therapy Efficacy Under Tumor Heterogeneity
Article Snippet: .. Then the membrane was incubated with each of the following primary antibodies overnight https://doi.org/10.3390/microorganisms14102156 at 4 ◦C, followed by washing 3 times with PBST: anti-GAPDH (1:10,000, Proteintech, Cat No. 60004-1-Ig, Wuhan, China), anti-POLR2G (1:1000, Proteintech, Cat No. 18497-1-AP, Wuhan, China), anti-SREBF1 (1:1000, Proteintech, Cat No. 14088-1-AP, Wuhan, China), antiTNFRSF1A (1:1000, Proteintech, Cat No. 21574-1-AP, Wuhan, China), anti-TNFAIP3 (1:1000, Proteintech, Cat No. 66695-1-Ig, Wuhan, China), anti-CASP9 (1:1000, Proteintech, Cat No. 10380-1-AP, Wuhan, China). .. Next, Goat anti-Mouse IgG (H + L) Secondary Antibody-HRP (1:10,000, Thermo Fisher Scientific, 31430, Waltham, MA, USA) or Goat anti-Rabbit IgG (H + L) Secondary Antibody-HRP (1:10,000, Thermo Fisher Scientific, 31460, Waltham, MA, USA) was added and incubated for 45 min at room temperature.

Article Title: A Mitochondria-Modulating Nanosystem for Rheumatoid Arthritis Immunotherapy via Inflammatory Cascade Disruption.
Article Snippet: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation within joints, where macrophage-driven inflammatory cascade caused by mitochondrial dysfunction significantly contributes to the pathogenesis.. Through recruitment and activation of neutrophils from circulation, these macrophages promote the release of neutrophil extracellular traps (NETs) and generation of reactive oxygen species (ROS), leading to synovitis exacerbation and tissue damage.. To disrupt this closely linked cycle, we present a mitochondria-modulating nanosystem (NM@APDAase) targeting the inflammatory cascade for RA immunotherapy.

Incubation:

Article Title: Integrated Multi-Omics Analyses Identify Core Determinants Governing Newcastle Disease Virus Oncolytic Therapy Efficacy Under Tumor Heterogeneity
Article Snippet: .. Then the membrane was incubated with each of the following primary antibodies overnight https://doi.org/10.3390/microorganisms14102156 at 4 ◦C, followed by washing 3 times with PBST: anti-GAPDH (1:10,000, Proteintech, Cat No. 60004-1-Ig, Wuhan, China), anti-POLR2G (1:1000, Proteintech, Cat No. 18497-1-AP, Wuhan, China), anti-SREBF1 (1:1000, Proteintech, Cat No. 14088-1-AP, Wuhan, China), antiTNFRSF1A (1:1000, Proteintech, Cat No. 21574-1-AP, Wuhan, China), anti-TNFAIP3 (1:1000, Proteintech, Cat No. 66695-1-Ig, Wuhan, China), anti-CASP9 (1:1000, Proteintech, Cat No. 10380-1-AP, Wuhan, China). .. Next, Goat anti-Mouse IgG (H + L) Secondary Antibody-HRP (1:10,000, Thermo Fisher Scientific, 31430, Waltham, MA, USA) or Goat anti-Rabbit IgG (H + L) Secondary Antibody-HRP (1:10,000, Thermo Fisher Scientific, 31460, Waltham, MA, USA) was added and incubated for 45 min at room temperature.

Article Title: A SASP-related four-gene signature associated with intervertebral disc degeneration: integrated bioinformatics analysis and validation of pinocembrin as a therapeutic candidate.
Article Snippet: 1 Department of Orthopedic Surgery, The Third Affiliated Hospital, Jiangxi Medical College, First Hospital of Nanchang, Nanchang University, Nanchang, People’s Republic of China 2 Department of Orthopedic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China 3 Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Diseases, Nanchang 330006, People’s Republic of China 4 Department of Orthopedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China 5 Department of Otorhinolaryngology, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China Abstract Background Cellular senescence and the senescence-associated secretory phenotype (SASP) are increasingly recognized as contributors to intervertebral disc degeneration (IVDD).. However, clinically relevant SASP-related gene signatures and therapeutic implications remain incompletely defined.. Methods Two peripheral whole-blood transcriptomic datasets from GEO (GSE124272 and GSE150408) were integrated.

Article Title: A Mitochondria-Modulating Nanosystem for Rheumatoid Arthritis Immunotherapy via Inflammatory Cascade Disruption.
Article Snippet: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation within joints, where macrophage-driven inflammatory cascade caused by mitochondrial dysfunction significantly contributes to the pathogenesis.. Through recruitment and activation of neutrophils from circulation, these macrophages promote the release of neutrophil extracellular traps (NETs) and generation of reactive oxygen species (ROS), leading to synovitis exacerbation and tissue damage.. To disrupt this closely linked cycle, we present a mitochondria-modulating nanosystem (NM@APDAase) targeting the inflammatory cascade for RA immunotherapy.

other:

Article Title: Intercellular interaction licenses TNFα/IFNγ-induced cancer cell apoptosis through the NF2–YAP–TRAIL pathway
Article Snippet: The following antibodies were used for immunoblotting: anti-HSP90 (13171-1-AP; Proteintech), anti-caspase-8 (4790; Cell Signaling Technology), anti-β-actin (4970; Cell Signaling Technology), anti-GAPDH (HRP-60004; Proteintech), anti-Caspase8 (4790; Cell Signaling Technology), antiCaspase3 (9662; Cell Signaling Technology), anti-Caspase7 (9492; Cell Signaling Technology), anti-IRF1 (8478; Cell Signaling Technology), anti-NF2 (12888; Cell Signaling Technology), anti-YAP (14074; Cell Signaling Technology), anti-p-YAP (4911; Cell Signaling Technology), anti-TAZ (4883; Cell Signaling Technology), antiLAST1 (3477; Cell Signaling Technology), anti-LAST2 (5888; Cell Signaling Technology), anti-STAT1 (14994; Cell Signaling Technology), anti-IFNGR1 (ab134070; Abcam), anti-FADD (14906-1-AP; Proteintech), anti-TRAIL (27064-1-AP; Proteintech), anti-FAS (13098-1-AP; Proteintech), anti-TNFR1 (21574-1-AP; Proteintech), anti-Bid (2002; Cell Signaling Technology), HRP-conjugated anti-rabbit IgG (A0545; Sigma-Aldrich), and HRP-conjugated anti-mouse IgG (A9044; Sigma-Aldrich).

Blocking Assay:

Article Title: A SASP-related four-gene signature associated with intervertebral disc degeneration: integrated bioinformatics analysis and validation of pinocembrin as a therapeutic candidate.
Article Snippet: 1 Department of Orthopedic Surgery, The Third Affiliated Hospital, Jiangxi Medical College, First Hospital of Nanchang, Nanchang University, Nanchang, People’s Republic of China 2 Department of Orthopedic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People’s Republic of China 3 Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Diseases, Nanchang 330006, People’s Republic of China 4 Department of Orthopedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China 5 Department of Otorhinolaryngology, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China Abstract Background Cellular senescence and the senescence-associated secretory phenotype (SASP) are increasingly recognized as contributors to intervertebral disc degeneration (IVDD).. However, clinically relevant SASP-related gene signatures and therapeutic implications remain incompletely defined.. Methods Two peripheral whole-blood transcriptomic datasets from GEO (GSE124272 and GSE150408) were integrated.



Similar Products

90
Spatial Transcriptomics Inc spatial transcriptomics cell-type deconvolution
Spatial Transcriptomics Cell Type Deconvolution, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+cell-type+deconvolution/spatial+transcriptomics+deconvolution/pm40042520-512-24-23
Average 90 stars, based on 1 article reviews
spatial transcriptomics cell-type deconvolution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc spatial transcriptomics cell type deconvolution (cell2location) signal
Spatial Transcriptomics Cell Type Deconvolution (Cell2location) Signal, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+cell-type+deconvolution/spatial+transcriptomics+deconvolution/pm38760586-507-3-4
Average 90 stars, based on 1 article reviews
spatial transcriptomics cell type deconvolution (cell2location) signal - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results